Omeros (OMER) EBITDA Margin (2010 - 2026)
Omeros' EBITDA Margin was 0.94% in Q2 2026, up 174.61 percentage points from the prior quarter.
Powered by 
Analysis
Omeros (OMER) EBITDA Margin (2010 - 2026) Analysis & Trends
On a trailing twelve-month basis, Omeros' EBITDA Margin was -187.17% through Jun 30, 2026, up 42.42 percentage points year-over-year; for FY2020, it was -210.40%, down 81.39 percentage points from FY2019.
- EBITDA Margin shows a five-year change of +315.39 percentage points (FY2015 to FY2020).
- In earlier years, EBITDA Margin was -129.01% in FY2019 (+243.37 pp), -372.38% in FY2018 (-305.58 pp), -66.79% in FY2017 (+62.90 pp) and -129.70% in FY2016 (+396.09 pp).
- The Q2 2026 figure marks the highest quarterly EBITDA Margin in data going back to Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | 42.49% |
| 10 | Omeros | 1.27 Bn | 828.47 Mn | 27.73 Mn | 5.98% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.98% |
| Mar 31, 2026 | -158.92% |
| Sep 30, 2025 | -140.53% |
| Sep 30, 2021 | -130.30% |
| Jun 30, 2021 | -155.38% |
| Mar 31, 2021 | -211.26% |
| Dec 31, 2020 | -281.58% |
| Sep 30, 2020 | -84.31% |
| Jun 30, 2020 | -182.22% |
| Mar 31, 2020 | -88.13% |
| Dec 31, 2019 | -62.13% |
| Sep 30, 2019 | -27.95% |
| Jun 30, 2019 | -24.87% |
| Mar 31, 2019 | -76.50% |
| Dec 31, 2018 | -76.52% |
| Sep 30, 2018 | -724.09% |
| Jun 30, 2018 | -1,837.52% |
| Mar 31, 2018 | -1,729.60% |
| Dec 31, 2017 | -101.01% |
| Sep 30, 2017 | -22.93% |
API Access
Omeros EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OMER&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "OMER", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=OMER&period=max&api_key=YOUR_API_KEY");
const data = await res.json();